Weekly Fund Digest - December 29, 2025 | VC & PE Form D Filings

Note: "Amount Raised" reflects the total offering amount disclosed in SEC Form D filings. Funds reporting $0 are excluded from this digest. AUM data is sourced from Form ADV filings where available.

Venture Capital

Top by Amount Raised

Helena Special Investments Fund II LP filed for $200.0 million from their Los Angeles, CA headquarters, helena Special Investments Fund II LP is the second private‑equity vehicle managed by Helena Special Investments, LLC, the for‑profit arm of the global Helena organization that creates and funds businesses aimed at solving societal problems while delivering attractive returns ([helena.org](https://helena.org/our-process)). The fund’s strategy focuses on investing in for‑profit ventures within energy, climate‑tech and cleantech sectors that can provide transformative impact ([orrimpact.com](https://www.orrimpact.com/portfolio-companies/helena)). Specific portfolio companies have not been disclosed in the publicly available sources.

HSI M42 SPV LP filed for $30.1 million from their Los Angeles, CA headquarters, hSI M42 SPV LP is managed by Hemisfério Sul Investimentos (HSI), a leading Latin‑American alternative‑investment firm that evolved from Prosperitas Investimentos in 2012 and now oversees over BRL 13 billion in assets ([hsml.hsifii.com](https://hsml.hsifii.com/en/the-fund-manager/timeline); [hsinvest.com](https://www.hsinvest.com/en/nossos-negocios)). The vehicle targets mid‑market Brazilian opportunities through a blend of private‑credit and real‑estate‑linked strategies, concentrating on sectors such as shopping malls, logistics, hospitality and other income‑producing assets ([hsinvest.com](https://www.hsinvest.com/en/nossos-negocios)). Specific portfolio companies have not been publicly disclosed in available sources.

Sixth Millennium Venture Partners Fund I, LP filed for $7.0 million from their JERUSALEM, L3 headquarters, sixth Millennium Venture Partners Fund I, LP is an early‑stage technology VC registered in Luxembourg with a strong European DNA, led by General Partner Jonathan Pacifici and focused on Israeli founders building global companies ([sixthmillennium.com](https://www.sixthmillennium.com); [signal.nfx.com](https://signal.nfx.com/firms/sixth-millennium-venture-partners)). The fund targets seed‑stage investments of $250 k–$1 M in sectors such as artificial intelligence, data and analytics, SaaS, AgriTech, autonomous technologies and other B2B solutions ([o.parsers.vc](https://o.parsers.vc/fund/sixthmillennium.com); [signal.nfx.com](https://signal.nfx.com/firms/sixth-millennium-venture-partners)). Notable portfolio companies include Novacy, an AI‑driven sales‑intelligence platform, among a small but focused set of early‑stage startups ([sixthmillennium.com](https://www.sixthmillennium.com)).

YCL AI Infra a Series of CGF2021 LLC filed for $2.1 million from their CLAYMONT, DE headquarters, yCL AI Infra, a Series of CGF2021 LLC, manages the Global AI Infrastructure Fund launched in early 2024 to back the foundational assets of tomorrow’s AI ecosystem ([aiinfra.fund](https://www.aiinfra.fund)). Its investment strategy concentrates on AI‑optimized data‑center infrastructure, specialty AI chips, and cloud services tailored for AI workloads, though no specific portfolio companies have been publicly disclosed ([aiinfra.fund](https://www.aiinfra.fund)).

Apex V a Series of CGF2021 LLC filed for $1.5 million from their CLAYMONT, DE headquarters, i’m unable to locate specific details about “Apex V a Series of CGF2021 LLC” in the provided sources, so I cannot provide a background, strategy, or portfolio companies for that entity. ([search results](#))

Private Equity

Top by Amount Raised

1315 Capital CPI Co-Invest, L.P. filed for $20.5 million from their PHILADELPHIA, PA headquarters, 1315 Capital CPI Co‑Invest, L.P. is a co‑investment vehicle of 1315 Capital, a Philadelphia‑based private‑equity firm founded in 2014 that manages over $1 billion of assets and focuses exclusively on growth‑stage healthcare companies ([1315capital.com/about](https://1315capital.com/about)) ([parsers.vc/fund/1315capital.com](https://parsers.vc/fund/1315capital.com)). The firm targets $5‑$50 million equity investments in commercial‑stage businesses across four verticals—healthcare services, pharma/medtech products, pharma/medtech outsourcing, and health & wellness—aiming to scale companies to $50‑$200 million in revenue through capital support and operational partnership ([1315capital.com/about-us](https://www.1315capital.com/about-us)) ([1315capital.com/investment-criteria](https://1315capital.com/investment-criteria)). Notable portfolio companies include Innovative ECMO and Experic, both healthcare‑focused firms backed by 1315 Capital ([tracxn.com/venture-capital/1315-capital/portfolio](https://tracxn.com/d/venture-capital/1315-capital/__0CBT-itXy5Q_hhjJVuTg9p03nidx12sTGiXZGRDk4Ko)).